{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:36:56Z","timestamp":1793317016668,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005084","name":"Beijing Excellent Ph.D. Thesis Guidance Foundation","doi-asserted-by":"publisher","award":["YXJL-2020-1225-0323"],"award-info":[{"award-number":["YXJL-2020-1225-0323"]}],"id":[{"id":"10.13039\/501100005084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Triple-negative breast cancer (TNBC) is a subtype characterized by the absence of common BC receptors and is closely associated with a hypoxic tumor microenvironment. However, the mechanisms through which TNBCs adapt to hypoxia remain elusive. This study revealed elevated\n                    <jats:italic>ENO1<\/jats:italic>\n                    levels in various BC datasets and revealed ENO1 protein lactylation in BC samples through 4D label-free lactylation quantitative proteomics analysis. The results indicated that lactylation increases ENO1 protein stability and enzyme activity, which promotes glycolysis. Notably, as lactate levels increased, a positive feedback loop was established, further promoting lactylation of ENO1. This positive feedback mechanism enables TNBC cells to adapt more efficiently to hypoxia and enhances their malignant behaviors. Lactylation prevented the lysosomal degradation of ENO1. In this study, the characteristics of ENO1, an RNA-binding protein, were assessed to determine how to interfere with its lactylation; specifically, an RNA ligand that can be specifically bound by ENO1 was identified. The RNA ligand was found to be linked to the Lamp2a protein in adipose stem cells (ADSCs) after stable transfection with Lamp2a-TAT and TRA-ligand plasmids. ADSCs seeded in a polyglycolic acid scaffold secreted exosomes containing the Lamp2a-linked ligand. This RNA ligand binds to ENO1 after it enters TNBC cells and further induces the lysosomal degradation of ENO1 by the Lamp2a protein. Consequently, glycolysis, which is associated with malignant cell behaviors, is inhibited. Overall, this study elucidated the role of ENO1 lactylation-mediated glycolysis in TNBC adaptation to hypoxia and provides a strategy for targeting ENO1.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08517-3","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:24:26Z","timestamp":1772465066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Lamp2a-linked RNA secreted by ADSCs prevents ENO1\u2013lactylation\u2013glycolysis feedback and cell malignant behavior in triple-negative breast cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Shaoqiang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingshu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7202-6598","authenticated-orcid":false,"given":"Shu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenJing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-8866","authenticated-orcid":false,"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"8517_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/his.14786","volume":"82","author":"EA Rakha","year":"2023","unstructured":"Rakha EA, Tse GM, Quinn CM. An update on the pathological classification of breast cancer. Histopathology. 2023;82:5\u201316.","journal-title":"Histopathology"},{"key":"8517_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1101\/cshperspect.a040535","volume":"13","author":"NS Chandel","year":"2021","unstructured":"Chandel NS. Glycolysis. Cold Spring Harb Perspect Biol. 2021;13:10.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8517_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108690","volume":"112","author":"Z Ghanbari Movahed","year":"2019","unstructured":"Ghanbari Movahed Z, Rastegari-Pouyani M, Mohammadi MH, Mansouri K. Cancer cells change their glucose metabolism to overcome increased ROS: one step from cancer cell to cancer stem cell?. Biomed Pharmacother. 2019;112:108690.","journal-title":"Biomed Pharmacother"},{"key":"8517_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fnins.2015.00022","volume":"9","author":"MJ Rogatzki","year":"2015","unstructured":"Rogatzki MJ, Ferguson BS, Goodwin ML, Gladden LB. Lactate is always the end product of glycolysis. Front Neurosci. 2015;9:22.","journal-title":"Front Neurosci"},{"key":"8517_CR5","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256052","volume":"24","author":"J Jin","year":"2023","unstructured":"Jin J, Bai L, Wang D, Ding W, Cao Z, Yan P, et al. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 2023;24:e56052.","journal-title":"EMBO Rep"},{"key":"8517_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/PL00000910","volume":"58","author":"V Pancholi","year":"2001","unstructured":"Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci. 2001;58:902\u201320.","journal-title":"Cell Mol Life Sci"},{"key":"8517_CR7","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.7150\/ijbs.63556","volume":"17","author":"G Qiao","year":"2021","unstructured":"Qiao G, Wu A, Chen X, Tian Y, Lin X. Enolase 1, a moonlighting protein, as a potential target for cancer treatment. Int J Biol Sci. 2021;17:3981\u201392.","journal-title":"Int J Biol Sci"},{"key":"8517_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2017.1333882","volume":"6","author":"DS Sutaria","year":"2017","unstructured":"Sutaria DS, Jiang J, Elgamal OA, Pomeroy SM, Badawi M, Zhu X, et al. Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery. J Extracell Vesicles. 2017;6:1333882.","journal-title":"J Extracell Vesicles"},{"key":"8517_CR9","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1016\/j.molcel.2022.05.019","volume":"82","author":"I Huppertz","year":"2022","unstructured":"Huppertz I, Perez-Perri JI, Mantas P, Sekaran T, Schwarzl T, Russo F, et al. Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation. Mol Cell. 2022;82:2666\u201380.","journal-title":"Mol Cell"},{"key":"8517_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/0008-5472.CAN-12-2633","volume":"73","author":"V Maire","year":"2013","unstructured":"Maire V, Nemati F, Richardson M, Vincent-Salomon A, Tesson B, Rigaill G, et al. Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer. Cancer Res. 2013;73:813\u201323.","journal-title":"Cancer Res"},{"key":"8517_CR11","doi-asserted-by":"publisher","first-page":"e63712","DOI":"10.1371\/journal.pone.0063712","volume":"8","author":"V Maire","year":"2013","unstructured":"Maire V, Baldeyron C, Richardson M, Tesson B, Vincent-Salomon A, Gravier E, et al. TTK\/hMPS1 is an attractive therapeutic target for triple-negative breast cancer. PLoS ONE. 2013;8:e63712.","journal-title":"PLoS ONE"},{"key":"8517_CR12","doi-asserted-by":"publisher","first-page":"e0122333","DOI":"10.1371\/journal.pone.0122333","volume":"10","author":"S Maubant","year":"2015","unstructured":"Maubant S, Tesson B, Maire V, Ye M, Rigaill G, Gentien D, et al. Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells. PLoS ONE. 2015;10:e0122333.","journal-title":"PLoS ONE"},{"key":"8517_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0550-y","volume":"17","author":"P Jezequel","year":"2015","unstructured":"Jezequel P, Loussouarn D, Guerin-Charbonnel C, Campion L, Vanier A, Gouraud W, et al. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Res. 2015;17:43.","journal-title":"Breast Cancer Res"},{"key":"8517_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1148-6","volume":"21","author":"P Jezequel","year":"2019","unstructured":"Jezequel P, Kerdraon O, Hondermarck H, Guerin-Charbonnel C, Lasla H, Gouraud W, et al. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications. Breast Cancer Res. 2019;21:65.","journal-title":"Breast Cancer Res"},{"key":"8517_CR15","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21:1688\u201398.","journal-title":"Clin Cancer Res"},{"key":"8517_CR16","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1158\/0008-5472.CAN-14-0673","volume":"76","author":"P den Hollander","year":"2016","unstructured":"den Hollander P, Rawls K, Tsimelzon A, Shepherd J, Mazumdar A, Hill J, et al. Phosphatase PTP4A3 promotes triple-negative breast cancer growth and predicts poor patient survival. Cancer Res. 2016;76:1942\u201353.","journal-title":"Cancer Res"},{"key":"8517_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675\u20138.","journal-title":"Nat Biotechnol"},{"key":"8517_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346\u201352.","journal-title":"Nature"},{"key":"8517_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejca.2017.01.017","volume":"75","author":"MJ Duffy","year":"2017","unstructured":"Duffy MJ, Harbeck N, Nap M, Molina R, Nicolini A, Senkus E, et al. Clinical use of biomarkers in breast cancer: updated guidelines from the European Group on Tumor Markers (EGTM). Eur J Cancer. 2017;75:284\u201398.","journal-title":"Eur J Cancer"},{"key":"8517_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.soc.2014.03.003","volume":"23","author":"P Alluri","year":"2014","unstructured":"Alluri P, Newman LA. Basal-like and triple-negative breast cancers: searching for positives among many negatives. Surg Oncol Clin N Am. 2014;23:567\u201377.","journal-title":"Surg Oncol Clin N Am"},{"key":"8517_CR21","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121:2750\u201367.","journal-title":"J Clin Invest"},{"key":"8517_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03087-4","volume":"11","author":"T Yang","year":"2020","unstructured":"Yang T, Shu X, Zhang HW, Sun LX, Yu L, Liu J, et al. Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis. Cell Death Dis. 2020;11:870.","journal-title":"Cell Death Dis"},{"key":"8517_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41421-020-0183-x","volume":"6","author":"W Chen","year":"2020","unstructured":"Chen W, Zhang Z, Chang C, Yang Z, Wang P, Fu H, et al. A bioenergetic shift is required for spermatogonial differentiation. Cell Discov. 2020;6:56.","journal-title":"Cell Discov"},{"key":"8517_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"8517_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","volume":"29","author":"K Yang","year":"2022","unstructured":"Yang K, Fan M, Wang X, Xu J, Wang Y, Tu F, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ. 2022;29:133\u201346.","journal-title":"Cell Death Differ"},{"key":"8517_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nchembio.304","volume":"6","author":"T Schneider-Poetsch","year":"2010","unstructured":"Schneider-Poetsch T, Ju J, Eyler DE, Dang Y, Bhat S, Merrick WC, et al. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol. 2010;6:209\u201317.","journal-title":"Nat Chem Biol"},{"key":"8517_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.molcel.2018.04.011","volume":"70","author":"H Huang","year":"2018","unstructured":"Huang H, Tang S, Ji M, Tang Z, Shimada M, Liu X, et al. p300-mediated lysine 2-hydroxyisobutyrylation regulates glycolysis. Mol Cell. 2018;70:663\u201378.","journal-title":"Mol Cell"},{"key":"8517_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","volume":"17","author":"EM Bowers","year":"2010","unstructured":"Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, et al. Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol. 2010;17:471\u201382.","journal-title":"Chem Biol"},{"key":"8517_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110911","volume":"27","author":"R Du","year":"2024","unstructured":"Du R, Gao Y, Yan C, Ren X, Qi S, Liu G, et al. Sirtuin 1\/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis. iScience. 2024;27:110911.","journal-title":"iScience"},{"key":"8517_CR30","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1080\/15548627.2018.1491489","volume":"14","author":"AR Issa","year":"2018","unstructured":"Issa AR, Sun J, Petitgas C, Mesquita A, Dulac A, Robin M, et al. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain. Autophagy. 2018;14:1898\u2013910.","journal-title":"Autophagy"},{"key":"8517_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14712598.2021.1954156","volume":"22","author":"G Hamilton","year":"2022","unstructured":"Hamilton G, Teufelsbauer M. Adipose-derived stromal\/stem cells and extracellular vesicles for cancer therapy. Expert Opin Biol Ther. 2022;22:67\u201378.","journal-title":"Expert Opin Biol Ther"},{"key":"8517_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 2023;5:61\u201379.","journal-title":"Nat Metab"},{"key":"8517_CR33","doi-asserted-by":"publisher","first-page":"598626","DOI":"10.3389\/fonc.2020.598626","volume":"10","author":"A Naik","year":"2020","unstructured":"Naik A, Decock J. Lactate metabolism and immune modulation in breast cancer: a focused review on triple negative breast tumors. Front Oncol. 2020;10:598626.","journal-title":"Front Oncol"},{"key":"8517_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.breast.2016.08.014","volume":"30","author":"X Huang","year":"2016","unstructured":"Huang X, Li X, Xie X, Ye F, Chen B, Song C, et al. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer. Breast. 2016;30:39\u201346.","journal-title":"Breast"},{"key":"8517_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01832361","volume":"24","author":"E Warner","year":"1992","unstructured":"Warner E. Type B lactic acidosis and metastatic breast cancer. Breast Cancer Res Treat. 1992;24:75\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"8517_CR36","doi-asserted-by":"publisher","first-page":"47691","DOI":"10.18632\/oncotarget.17868","volume":"8","author":"X Qian","year":"2017","unstructured":"Qian X, Xu W, Xu J, Shi Q, Li J, Weng Y, et al. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer. Oncotarget. 2017;8:47691\u2013708.","journal-title":"Oncotarget"},{"key":"8517_CR37","first-page":"1946","volume":"11","author":"Y Gou","year":"2021","unstructured":"Gou Y, Li F, Huo X, Hao C, Yang X, Pei Y, et al. ENO1 monoclonal antibody inhibits invasion, proliferation and clone formation of cervical cancer cells. Am J Cancer Res. 2021;11:1946\u201361.","journal-title":"Am J Cancer Res"},{"key":"8517_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-016-0385-8","volume":"10","author":"M Principe","year":"2017","unstructured":"Principe M, Borgoni S, Cascione M, Chattaragada MS, Ferri-Borgogno S, Capello M, et al. Alpha-enolase (ENO1) controls alpha v\/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. J Hematol Oncol. 2017;10:16.","journal-title":"J Hematol Oncol"},{"key":"8517_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41420-022-01047-9","volume":"8","author":"Y Li","year":"2022","unstructured":"Li Y, Li Y, Luo J, Fu X, Liu P, Liu S, et al. FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K\/AKT signaling pathway. Cell Death Discov. 2022;8:248.","journal-title":"Cell Death Discov"},{"key":"8517_CR40","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1007\/s11033-022-07540-9","volume":"49","author":"K Zhang","year":"2022","unstructured":"Zhang K, Tian R, Zhang W, Li Y, Zeng N, Liang Y, et al. alpha-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma. Mol Biol Rep. 2022;49:8241\u201350.","journal-title":"Mol Biol Rep"},{"key":"8517_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","volume":"17","author":"Z Wang","year":"2020","unstructured":"Wang Z, Jiang Q, Dong C. Metabolic reprogramming in triple-negative breast cancer. Cancer Biol Med. 2020;17:44\u201359.","journal-title":"Cancer Biol Med"},{"key":"8517_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","volume":"33","author":"Y Gong","year":"2021","unstructured":"Gong Y, Ji P, Yang YS, Xie S, Yu TJ, Xiao Y, et al. Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets. Cell Metab. 2021;33:51\u201364 e59.","journal-title":"Cell Metab"},{"key":"8517_CR43","doi-asserted-by":"publisher","first-page":"1091779","DOI":"10.3389\/fphar.2022.1091779","volume":"13","author":"D Zhou","year":"2022","unstructured":"Zhou D, Duan Z, Li Z, Ge F, Wei R, Kong L. The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment. Front Pharmacol. 2022;13:1091779.","journal-title":"Front Pharmacol"},{"key":"8517_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia. 2015;3:83\u201392.","journal-title":"Hypoxia"},{"key":"8517_CR45","doi-asserted-by":"publisher","first-page":"652266","DOI":"10.3389\/fonc.2021.652266","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang H, Wang M, Schmid T, Xin Z, Kozhuharova L, et al. Hypoxia in breast cancer-scientific translation to therapeutic and diagnostic clinical applications. Front Oncol. 2021;11:652266.","journal-title":"Front Oncol"},{"key":"8517_CR46","doi-asserted-by":"publisher","first-page":"1199105","DOI":"10.3389\/fonc.2023.1199105","volume":"13","author":"N Srivastava","year":"2023","unstructured":"Srivastava N, Usmani SS, Subbarayan R, Saini R, Pandey PK. Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens. Front Oncol. 2023;13:1199105.","journal-title":"Front Oncol"},{"key":"8517_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/tra.12619","volume":"20","author":"MR Dores","year":"2019","unstructured":"Dores MR, Trejo J. Endo-lysosomal sorting of G-protein-coupled receptors by ubiquitin: diverse pathways for G-protein-coupled receptor destruction and beyond. Traffic. 2019;20:101\u20139. https:\/\/doi.org\/10.1111\/tra.12619.","journal-title":"Traffic"},{"key":"8517_CR48","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260101","volume":"136","author":"I Berlin","year":"2023","unstructured":"Berlin I, Sapmaz A, St\u00e9venin V, Neefjes J. Ubiquitin and its relatives as wizards of the endolysosomal system. J Cell Sci. 2023;136:jcs260101.","journal-title":"J Cell Sci"},{"key":"8517_CR49","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale B, Cheng M, Park KS, Kaniskan H\u00dc, Xiong Y, Jin J. Advancing targeted protein degradation for cancer therapy. Nat Rev Cancer. 2021;21:638\u201354.","journal-title":"Nat Rev Cancer"},{"key":"8517_CR50","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/15548627.2021.1963155","volume":"18","author":"X Zhao","year":"2022","unstructured":"Zhao X, Di Q, Yu J, Quan J, Xiao Y, Zhu H, et al. USP19 (ubiquitin specific peptidase 19) promotes TBK1 (TANK-binding kinase 1) degradation via chaperone-mediated autophagy. Autophagy. 2022;18:891\u2013908.","journal-title":"Autophagy"},{"key":"8517_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm1140","volume":"8","author":"JV Ferreira","year":"2022","unstructured":"Ferreira JV, da Rosa Soares A, Ramalho J, M\u00e1ximo Carvalho C, Cardoso MH, Pintado P, et al. LAMP2A regulates the loading of proteins into exosomes. Sci Adv. 2022;8:eabm1140.","journal-title":"Sci Adv"},{"key":"8517_CR52","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3892\/etm.2017.4705","volume":"14","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wang W, Wang X, Wang Y, Wang J, Fu Q, et al. Tissue-engineered sling with adipose-derived stem cells under static mechanical strain. Exp Ther Med. 2017;14:1337\u201342.","journal-title":"Exp Ther Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08517-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08517-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08517-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:02:50Z","timestamp":1774623770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08517-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8517"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08517-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The clinical study was approved by the ethics committee of Harbin Medical University Cancer Hospital. For the animal study, all the animals were treated and cared for in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, Revised 2011), and all the experimental procedures were approved by the Animal Care and Use Committee of Harbin Medical University Cancer Hospital (Approval number: KY2021-03).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from the patients for the publication of pathological tissue images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"288"}}